| Product NDC: | 60977-144 | 
| Proprietary Name: | Dopram | 
| Non Proprietary Name: | DOXAPRAM HYDROCHLORIDE | 
| Active Ingredient(s): | 20 mg/mL & nbsp; DOXAPRAM HYDROCHLORIDE | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 60977-144 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA014879 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20101129 | 
| Package NDC: | 60977-144-02 | 
| Package Description: | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) | 
| NDC Code | 60977-144-02 | 
| Proprietary Name | Dopram | 
| Package Description | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) | 
| Product NDC | 60977-144 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | DOXAPRAM HYDROCHLORIDE | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20101129 | 
| Marketing Category Name | NDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | DOXAPRAM HYDROCHLORIDE | 
| Strength Number | 20 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC] |